<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Five patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (RA: 4 cases, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in T: 1 case) were treated with myeloablative immunosuppressive therapy followed by bone marrow transplantation (BMT) </plain></SENT>
<SENT sid="1" pm="."><plain>Median age was 20-y-o (11-31-y-o) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were prepared with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and total body irradiation </plain></SENT>
<SENT sid="3" pm="."><plain>Engraftment was documented in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="4" pm="."><plain>One patients (case 4, 31-y-o female) died of brain <z:mp ids='MP_0001914'>hemorrhage</z:mp> due to the <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> refractory to platelet transfusion because of anti-<z:hpo ids='HP_0003454'>platelet antibody</z:hpo> in 34 days after BMT </plain></SENT>
<SENT sid="5" pm="."><plain>A patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in T was also died of <z:hpo ids='HP_0002093'>respiratory failure</z:hpo> from interstitial <z:hpo ids='HP_0002090'>pneumonia</z:hpo> on Day 173 </plain></SENT>
<SENT sid="6" pm="."><plain>One patient (case 1, 22-y-o, female) progressively became granulocytopenic and thrombocytopenic status after BMT </plain></SENT>
<SENT sid="7" pm="."><plain>She suffered from life-threatening <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and then received a second bone marrow cell infusion from the same donor without any preparative conditioning </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that BMT could be the treatment of choice for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, especially for the patients with RA who have poor prognostic factors including life-threatening cytopenia and or cytogenetical abnormalities </plain></SENT>
</text></document>